Search for: "SANDOZ, INC." Results 21 - 40 of 680
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Dec 2010, 9:59 pm by Patent Docs
Sandoz, Inc., the Federal Circuit vacated the entry of a consent judgment and an injunction by the District Court for the District of New Jersey, which enjoined Defendants-Appellants Sun Pharmaceutical Industries, Ltd. and Caraco Pharmaceutical Laboratories, Ltd. [read post]
15 Apr 2017, 8:47 pm by Patent Docs
As part of its ongoing Supreme Court series, the American University Washington College of Law Program on Information Justice & Intellectual Property will be hosting a post-argument discussion on the Sandoz Inc. v. [read post]
22 Dec 2022, 3:15 pm by Lawrence B. Ebert
Sandoz, Inc., No. 19-0078, 2022 WL 842957 (D. [read post]
10 Sep 2009, 9:59 pm
Sandoz, Inc.(1), arose as the result of ANDA filings by several Defendants for oxaliplatin, the active ingredient in Sanofi's Eloxatin ® colorectal cancer drug. [read post]
14 Oct 2015, 9:59 pm by Patent Docs
Noonan -- Last week the Federal Circuit affirmed a District Court's finding of invalidity and non-infringement in ANDA litigation between Spectrum Pharmaceuticals and Sandoz. [read post]
1 May 2013, 9:59 pm by Patent Docs
Sandoz that a claimed method for treating glaucoma (which differed from the three-times-a-day dosage regimens required of the individual components) was not inherently obvious, and thereby prevented a group of generic challengers from being able to market their own versions of Combigan® before the expiration of the patent containing the claimed method. [read post]
16 Sep 2011, 11:03 am by eithurburn@getnicklaw.com
Sandoz, Inc. is the latest company to fall in an ongoing series of litigation surrounding fraudulent manipulation of Medicaid’s Average Wholesale Price by pharmaceutical companies. [read post]
26 Apr 2017, 9:59 pm by Patent Docs
By Andrew Williams -- Earlier today, the Supreme Court heard oral arguments in Sandoz Inc. v. [read post]
7 Jan 2015, 10:46 am by Morse, Barnes-Brown Pendleton
By: David Fazzolare On January 5, 2015, the US Food and Drug Administration’s (“FDA’s”) Oncologic Drugs Advisory Committee (the “Committee”) announced its recommendation that the FDA approve Sandoz Inc. [read post]
24 Feb 2009, 9:58 pm
News from Alabama yesterday:Jurors ordered Sandoz Inc. pay the State Government of Alabama $78.4 million for causing the state Medicaid program to pay too much for prescription drugs from 1991 to 2005.Evidence at trial? [read post]
9 Oct 2014, 9:59 pm by Patent Docs
Sandoz Inc. case to determine whether appellate courts should afford any deference to a trial court's claim construction determination. [read post]
27 Aug 2017, 9:34 pm by Patent Docs
District Court for the District of Massachusetts allowed a motion for judgment as a matter of law filed by Plaintiffs Momenta Pharmaceuticals, Inc. and Sandoz Inc. [read post]